As their use continues to grow, there is also increasing interest in understanding potential GLP-1 side effects and how they may affect daily life
However, no significant differences were detected in other outcomes, including nonmotor symptoms, cognition, finger tapping, walking speed, and levodopa equivalent dose [97]
Those who relied primarily on the medication without lifestyle modifications face higher risks of regaining weight
Primary research pairing In experimental research settings, Retatrutide is frequently examined alongside compounds involved in growth hormonerelated signaling pathways
For instance, a 17-month study revealed sustained weight loss among participants, with average reductions of 15.0% for the 5 mg dose, 19.5% for the 10 mg dose, and 20.9% for the 15 mg dose
Once-Weekly Convenience vs